Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal de Groote

Showing results (21-30 of 156) with videos related to

Pageof 16
Sort By:
Journal of the American College of Cardiology|May 4, 2004
B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failurePascal de Groote, Joël Dagorn, Benoit Soudan, et al.
Congestive Heart Failure (Greenwich, Conn.)|August 4, 2007
Prevalence and determinants of cognitive impairment in chronic heart failure patientsStéphanie Debette, Christophe Bauters, Didier Leys, et al.
International Journal of Cardiology|December 21, 2010
Cardiac magnetic resonance imaging of mucopolysaccharidosis type II cardiomyopathyMeriem Mostefa Kara, Pascal de Groote, Georges Abboud, et al.
Heart (British Cardiac Society)|June 21, 2014
Prognostic impact of ß-blocker use in patients with stable coronary artery diseaseChristophe Bauters, Gilles Lemesle, Thibaud Meurice, et al.
Circulation. Heart Failure|February 25, 2014
Long-term functional and clinical follow-up of patients with heart failure with recovered left ventricular ejection fraction after β-blocker therapyPascal de Groote, Marie Fertin, Anju Duva Pentiah, et al.
Presse Medicale (Paris, France : 1983)|May 4, 2011
[Systemic sclerosis associated pulmonary arterial hypertension: the pitfalls]Eric Hachulla, David Launay, Jérôme Le Pavec, et al.
ESC Heart Failure|February 8, 2020
Rationale and design of the CardioMEMS Post-Market Multinational Clinical Study: COASTMartin R Cowie, Pascal de Groote, Scott McKenzie, et al.
European Journal of Heart Failure|March 12, 2004
Beta-adrenergic receptor blockade and the angiotensin-converting enzyme deletion polymorphism in patients with chronic heart failurePascal de Groote, Nicole Helbecque, Nicolas Lamblin, et al.
European Heart Journal|September 27, 2005
High-sensitivity C-reactive protein: potential adjunct for risk stratification in patients with stable congestive heart failureNicolas Lamblin, Frédéric Mouquet, Bernadette Hennache, et al.
Archives of Cardiovascular Diseases|September 5, 2016
Effect of left ventricular systolic dysfunction on secondary medical prevention and clinical outcome in stable coronary artery disease patientsNicolas Lamblin, Thibaud Meurice, Olivier Tricot, et al.
Pageof 16

Showing results (21-30 of 156) with videos related to

Sort By:
Pageof 16
Journal of the American College of Cardiology|May 4, 2004
B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failurePascal de Groote, Joël Dagorn, Benoit Soudan, et al.
Congestive Heart Failure (Greenwich, Conn.)|August 4, 2007
Prevalence and determinants of cognitive impairment in chronic heart failure patientsStéphanie Debette, Christophe Bauters, Didier Leys, et al.
International Journal of Cardiology|December 21, 2010
Cardiac magnetic resonance imaging of mucopolysaccharidosis type II cardiomyopathyMeriem Mostefa Kara, Pascal de Groote, Georges Abboud, et al.
Heart (British Cardiac Society)|June 21, 2014
Prognostic impact of ß-blocker use in patients with stable coronary artery diseaseChristophe Bauters, Gilles Lemesle, Thibaud Meurice, et al.
Circulation. Heart Failure|February 25, 2014
Long-term functional and clinical follow-up of patients with heart failure with recovered left ventricular ejection fraction after β-blocker therapyPascal de Groote, Marie Fertin, Anju Duva Pentiah, et al.
Presse Medicale (Paris, France : 1983)|May 4, 2011
[Systemic sclerosis associated pulmonary arterial hypertension: the pitfalls]Eric Hachulla, David Launay, Jérôme Le Pavec, et al.
ESC Heart Failure|February 8, 2020
Rationale and design of the CardioMEMS Post-Market Multinational Clinical Study: COASTMartin R Cowie, Pascal de Groote, Scott McKenzie, et al.
European Journal of Heart Failure|March 12, 2004
Beta-adrenergic receptor blockade and the angiotensin-converting enzyme deletion polymorphism in patients with chronic heart failurePascal de Groote, Nicole Helbecque, Nicolas Lamblin, et al.
European Heart Journal|September 27, 2005
High-sensitivity C-reactive protein: potential adjunct for risk stratification in patients with stable congestive heart failureNicolas Lamblin, Frédéric Mouquet, Bernadette Hennache, et al.
Archives of Cardiovascular Diseases|September 5, 2016
Effect of left ventricular systolic dysfunction on secondary medical prevention and clinical outcome in stable coronary artery disease patientsNicolas Lamblin, Thibaud Meurice, Olivier Tricot, et al.
Pageof 16